NCT06784830 · RECRUITING
Nursing Interventions for Alzheimer's Patients During PET/CT Imaging
This trial is testing whether specific nursing care techniques used during PET/CT brain scans improve the quality of the images produced and leave patients feeling less anxious and more satisfied with the experience. It enrolls 200 people already diagnosed with Alzheimer's disease. Phase NA means this is not a drug or device trial — it is a care process study, with no phase classification needed.
You may qualify if
- Meet the criteria for diagnosing dementia as described in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-R), Use the diagnostic criteria for AD from the National Institute of Neurology, Speech and Communication Disorders and Stroke - Alzheimer's Disease and Related Disorders (NINCDS-ADRDA) or the National Institute on Aging and Alzheimer's Disease Association (NIA-AA).
You're excluded if
- Patients with a history of stroke and focal neurological signs, and imaging findings consistent with small cerebral vascular disease (Fazekas score ≥2);
- The presence of other neurological disorders that can cause brain dysfunction (e.g., depression, brain tumors, Parkinson's disease, metabolic encephalopathy, encephalitis, multiple sclerosis, epilepsy, brain trauma, Normal facial pressure hydrocephalus);
- The presence of other systemic diseases that can cause cognitive impairment (such as liver insufficiency, renal insufficiency, thyroid dysfunction, severe anemia, folic acid or vitamin B12 deficiency, syphilis, HIV infection, alcohol and drug abuse, etc.);
- There is mental and neurological retardation.
- There are other diseases that are known to cause cognitive impairment.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-02-14